Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 7, 2013
Purpose: Regulation FD Disclosure to furnish information from a PowerPoint presentation delivered to institutional investors and analysts. The presentation updates and replaces all prior presentations filed by the company.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely as a vehicle to disclose the existence of an investor presentation (Exhibit 99.1) rather than reporting specific financial data within the text of the 8-K itself.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document notes that the attached presentation updates and replaces all prior PowerPoint presentations filed by the registrant.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The company expressly disclaims any obligation to release publicly any updates or changes in expectations, events, conditions, or circumstances on which forward-looking statements are based.
- Liability Disclaimer: Information furnished pursuant to Item 7.01 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
- Availability: The text of the presentation is available on the company website, though the company reserves the right to discontinue availability at any time.
Investor Verification Checklist
- Review Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated October 2013) for specific financial data and strategic updates, as the 8-K text contains no numerical metrics.
- Verify the current availability of the presentation on the company website (www.therapeuticsmd.com), noting the company's right to remove it.
- Confirm that no subsequent filings have superseded the October 2013 presentation.